These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16400232)

  • 21. Can a diagnosis of renal allograft rejection be based on histology alone?
    Midtvedt K; Hartmann A; Sund S
    Clin Transplant; 1998 Aug; 12(4):300-2. PubMed ID: 9686323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety.
    Laftavi MR; Stephan R; Stefanick B; Kohli R; Dagher F; Applegate M; O'Keefe J; Pierce D; Rubino A; Guzowski H; Leca N; Dayton M; Pankewycz O
    Surgery; 2005 Mar; 137(3):364-71. PubMed ID: 15746793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential predictive markers in protocol biopsies for premature renal graft loss.
    Matl I; Hribova P; Honsova E; Brabcova I; Viklicky O
    Kidney Blood Press Res; 2010; 33(1):7-14. PubMed ID: 20090361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histologic findings in protocol biopsies of transplanted kidneys].
    Tichý T; Tichý M; Zadrazil J; Krejcí K; Horcicka V; al-Jabry S; Bachleda P; Král V; Dusek J
    Cesk Patol; 2003 Jan; 39(1):11-6. PubMed ID: 12673937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early subclinical rejection as a risk factor for late chronic humoral rejection.
    Moreso F; Carrera M; Goma M; Hueso M; Sellares J; Martorell J; Grinyó JM; Serón D
    Transplantation; 2012 Jan; 93(1):41-6. PubMed ID: 22094957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients.
    Legendre C; Thervet E; Skhiri H; Mamzer-Bruneel MF; Cantarovich F; Noël LH; Kreis H
    Transplantation; 1998 Jun; 65(11):1506-9. PubMed ID: 9645814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts.
    Gough J; Rush D; Jeffery J; Nickerson P; McKenna R; Solez K; Trpkov K
    Nephrol Dial Transplant; 2002 Jun; 17(6):1081-4. PubMed ID: 12032200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection.
    Tsuji T; Yanai M; Itami H; Ishii Y; Akimoto M; Fukuzawa N; Harada H; Fukasawa Y
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():26-30. PubMed ID: 26031582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome.
    Vallejos A; Alperovich G; Moreso F; Cañas C; de Lama ME; Gomà M; Fulladosa X; Carrera M; Hueso M; Grinyó JM; Serón D
    Nephrol Dial Transplant; 2005 Nov; 20(11):2511-6. PubMed ID: 16077142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients.
    Helantera I; Koskinen P; Tornroth T; Loginov R; Gronhagen-Riska C; Lautenschlager I
    Transplantation; 2003 Jun; 75(11):1858-64. PubMed ID: 12811246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes.
    Hrubá P; Brabcová I; Gueler F; Krejčík Z; Stránecký V; Svobodová E; Malušková J; Gwinner W; Honsová E; Lodererová A; Oberbauer R; Zachoval R; Viklický O
    Kidney Int; 2015 Oct; 88(4):785-95. PubMed ID: 26176825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of subclinical injuries detected by protocol biopsy improves the long-term kidney allograft function: a single center prospective randomized clinical trial.
    Szederkényi E; Iványi B; Morvay Z; Szenohradszki P; Borda B; Marofka F; Kemény E; Lázár G
    Transplant Proc; 2011 May; 43(4):1239-43. PubMed ID: 21620099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing and value of protocol biopsies in well-matched kidney transplant recipients--a clinical and histopathologic analysis.
    Helanterä I; Ortiz F; Helin H; Räisänen-Sokolowski A; Honkanen E; Koskinen P
    Transpl Int; 2007 Nov; 20(11):982-90. PubMed ID: 17711407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protocol transplant biopsies: are they really needed?
    Wilkinson A
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):130-7. PubMed ID: 17699199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical rejection and borderline changes in early protocol biopsy specimens after renal transplantation.
    Roberts IS; Reddy S; Russell C; Davies DR; Friend PJ; Handa AI; Morris PJ
    Transplantation; 2004 Apr; 77(8):1194-8. PubMed ID: 15114084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of renal allograft biopsies with "borderline changes," as defined in the Banff Schema.
    Saad R; Gritsch HA; Shapiro R; Jordan M; Vivas C; Scantlebury V; Demetris AJ; Randhawa PS
    Transplantation; 1997 Oct; 64(7):992-5. PubMed ID: 9381547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of protocol biopsies in living related renal transplant recipients.
    Varma M; Guleria S; Gupta S; Dinda AK; Agarwal SK; Mahajan S; Bhowmik D; Tiwari SC; Dash SC
    Transplant Proc; 2006 Sep; 38(7):2016-7. PubMed ID: 16979984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss.
    Moreso F; Ibernon M; Gomà M; Carrera M; Fulladosa X; Hueso M; Gil-Vernet S; Cruzado JM; Torras J; Grinyó JM; Serón D
    Am J Transplant; 2006 Apr; 6(4):747-52. PubMed ID: 16539631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular markers in subclinical acute rejection of renal transplants.
    Aquino Dias EC; Veronese FJ; Santos Gonçalves LF; Manfro RC
    Clin Transplant; 2004 Jun; 18(3):281-7. PubMed ID: 15142049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.